
Sign up to save your podcasts
Or
Mr. Chet Burrell, former president and CEO of Care First Blue Cross Blue Shield and Executive Chairman of the Intervention Insights Board of Directors, discusses the challenges payers face in managing the growth of precision medicine for cancer care and why he's championing Trapelo's precision diagnostic platform as the first collaborative technology solution.
4.8
3333 ratings
Mr. Chet Burrell, former president and CEO of Care First Blue Cross Blue Shield and Executive Chairman of the Intervention Insights Board of Directors, discusses the challenges payers face in managing the growth of precision medicine for cancer care and why he's championing Trapelo's precision diagnostic platform as the first collaborative technology solution.
38,749 Listeners
4,194 Listeners
1,651 Listeners
169 Listeners
5,980 Listeners
58,104 Listeners
29,378 Listeners
18,608 Listeners
20,212 Listeners
5 Listeners